Biotech Startups

CellaVision is a provider of digital hematology microscopy solutions including analyzers, instruments, reagents, and software that automate workflow in hematology laboratories. The company serves clinical and veterinary laboratories globally with digital cell morphology tools to minimize human error and streamline data management.

1 investor

Cellbox Solutions develops portable incubators with active CO₂ and temperature control to transport living cells and biological samples at constant laboratory conditions (37°C, 5% CO₂). The company serves the global biomedical industry and works with over 150 customers on cell transport logistics.

1 investor

CellBri provides modular, automated cell processing systems for preparing cells for therapeutic applications. The company offers enclosed, turnkey solutions that can automate individual steps or complete workflows, from cell harvesting and separation through expansion and cryopreservation.

1 investor

CellCarta is a contract research organization providing biomarker discovery, assay development, and clinical trial execution services for pharmaceutical companies and biotechs. It offers multi-omic biomarker insights, regulatory-ready data generation, and regulatory support for assay development and IVDR submissions across preclinical and clinical therapeutic programs.

1 investor

Cellcolabs manufactures bone marrow-derived mesenchymal stem cells (MSCs) at industrial scale using its GMP-certified Cellcolabs Protocol, a standardized and validated production process. The company supplies pharmaceutical-grade stem cells to support clinical research and global collaborations in the field of advanced cell therapies.

1 investor

Cellcraft develops cultivated meat technology and bio-manufacturing systems that use AI and bioreactors to produce meat locally without animals. The company enables food producers to manufacture cultured meat tailored to local tastes while reducing environmental impact, antimicrobial resistance, and production costs.

1 investor

CellCrine develops a chemically defined supplement (BAP-CDS) based on a Bio-Activated Protein, used as a serum-free replacement for Fetal Bovine Serum in cell culture across a wide range of cell types including stem cells, primary cells, and cell lines. The product targets researchers and cultivated-meat/biomanufacturing applications requiring chemically defined media.

1 investor

Celldex is a biotechnology company developing therapeutics across therapeutic areas including immunology and inflammation. The page shown is a board director biography rather than a company overview.

1 investor

CELLECT develops nanomaterial-embedded menstrual products (tampons and pads) that non-invasively collect and preserve DNA from menstrual blood for screening of HPV, cervical cancer, and STDs. The collection system is compatible with existing diagnostic assays and targets women seeking an at-home alternative to Pap smears, including underserved communities.

1 investor

Cellectis is a biotech company focused on cell therapy and immunotherapy. The company is publicly listed on Nasdaq and Euronext Growth Paris.

1 investor

Cellemedy develops next-generation therapeutic proteins designed to replace conventional antibody treatments in healthcare.

1 investor

Cellera Farma is a Brazilian pharmaceutical company that manages a portfolio of established medical products through partnerships, licensing, distribution, promotion, and proprietary products. It focuses on therapeutic areas including central nervous system, gastroenterology, orthopedics, and pediatrics.

1 investor

Cellergy develops allogeneic mitochondrial transplantation therapy, producing GMP-grade purified mitochondria from human primary cells for intravenous, repeated administration. Its therapy targets systemic and degenerative conditions such as CNS disorders, muscle degeneration, and aging, and uses a machine-learning model to predict donor/recipient matching.

1 investor

Cellergy Pharma develops immunotherapies for patients with severe allergic disease and cancer.

1 investor

IngenOx Therapeutics is a clinical-stage biopharmaceutical company developing precision drugs and cancer vaccines for patients with advanced, treatment-resistant cancers that evade the immune system. Based in Oxford, UK, it uses an in-house discovery platform for both small-molecule drug development and vaccine development targeting immunologically cold tumours.

1 investor

Cellestial Health is a preclinical-stage biotech developing therapies for Parkinson's disease, with a lead candidate rooted in astrocytic network biology. The company focuses on drug discovery for neurological disease.

1 investor

CELLINK develops 3D bioprinters along with bioinks and biomaterials for 3D cell culture, serving cell biologists, tissue engineers, and biomedical researchers. Its technology is applied in personalized medicine, drug discovery, regenerative medicine, and cell-cultured food.

1 investor

Cellipont Bioservices is a contract development and manufacturing organization (CDMO) that provides GMP manufacturing and development services for advanced cell therapies. It serves pharma and biotech clients developing cell therapy treatments.

1 investor

CellMax Life appears to be a diagnostics company, though the page provided only contains a biography of John Sninsky (Chief Scientific Officer) with no explicit company description, products, or business model stated.

1 investor

CellON develops plant and wood-based material technologies, including SuperFibre and Nanogel products, designed to replace synthetic materials in applications requiring oil resistance, fire prevention, or antimicrobial properties. The company serves manufacturers seeking sustainable, biodegradable alternatives free from toxic chemicals.

1 investor

Cellpurics is a South Korean biotech company focused on stem cell technologies, including large-scale gonadal stem cell cultivation and storage, Real-time PCR-based measurement of mesenchymal stem cell anti-inflammatory capacity, and high-tech companion animal diagnostics. It also provides contract research organization (CRO) services covering in vitro and in vivo drug efficacy evaluation, veterinary drug and medical device clinical trials, GLP toxicity testing, and AI-based drug discovery.

1 investor

CellsBin develops an AI-driven photonic semiconductor platform for detecting, isolating, and characterizing rare cells in biological samples for therapeutic monitoring and precision medicine applications. The company serves researchers and clinicians in drug development, cell therapy monitoring, and clinical diagnostics.

1 investor

A biotech company developing cell and gene technology solutions focused on regenerative medicine and advancing healthcare innovations.

1 investor

CellTivity Scientific provides point-of-care biopsy assessment technology to improve cancer diagnosis accuracy and speed. The company aims to reduce diagnostic delays and uncertainty while preparing samples for next-generation sequencing.

1 investor